ag 112 has been researched along with ag 99 in 2 studies
| Studies (ag 112) | Trials (ag 112) | Recent Studies (post-2010) (ag 112) | Studies (ag 99) | Trials (ag 99) | Recent Studies (post-2010) (ag 99) |
|---|---|---|---|---|---|
| 19 | 0 | 10 | 32 | 0 | 6 |
| Protein | Taxonomy | ag 112 (IC50) | ag 99 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 7.6381 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 6.4283 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CJ; Geahlen, RL | 1 |
| Gazit, A; Gilon, C; Levitzki, A; Yaish, P | 1 |
1 review(s) available for ag 112 and ag 99
| Article | Year |
|---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |
1 other study(ies) available for ag 112 and ag 99
| Article | Year |
|---|---|
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
Topics: Benzylidene Compounds; Carcinoma, Squamous Cell; Cell Division; Cell Line; Epidermal Growth Factor; ErbB Receptors; Humans; Kinetics; Molecular Structure; Nitriles; Phosphorylation; Protein-Tyrosine Kinases; Structure-Activity Relationship | 1989 |